Rapid antibody test for tick-borne encephalitis (TBE) immunity assessment, delivering results within 20 minutes. Clinical evaluation shows sensitivity of 99.3% and specificity of 100% for vaccine-induced protection evaluation.
Manufactured by
Rainbach im Muehlkreis, Austria
GENSPEED Biotech GmbH – Rapid Multiplex Diagnostics in Laboratory Quality GENSPEED Biotech develops and manufactures rapid diagnostic tests that combine laboratory accuracy with true point-of-care convenience . Our proprietary GENSPEED® Multiplex Micro-ELISA Platform delivers quantitative, lab-quality results within 15–20 minutes from a single drop of capillary blood or other biological samples. The technology integrates microfluidics, chemiluminescence detection, and multiplexed ELISA chemistry in a compact, cartridge-based format. It enables simultaneous quantification of up to eight biomarkers, providing comprehensive diagnostic insights directly at the point of need — in pharmacies, doctors offices, clinics, and research laboratories. GENSPEED is IVDR-certified and already offers CE-marked assays such as the Vitamin D xPOC , FSME (TBE) IgG xPOC , COVID-19 IgG xPOC , and PerioPOC Pro tests. Current developments include multiplex assays for prosthetic joint infection (PJI) , process analytical testing for biopharmaceutical manufacturing (HEK293 HCP assay) and other applications. Our vision is to bring laboratory diagnostics to the point of care – enabling faster, data-driven medical decisions that improve patient outcomes and strengthen healthcare accessibility.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Reagena Oy
Finland · 6 relevant products
Citest Diagnostics Inc.
Canada · 4 relevant products
Hangzhou Frenovo Biotech Co., Ltd
China · 6 relevant products
VEDALAB SAS
France · 4 relevant products
Prometheus Bio Inc.
China · 2 relevant products
Access Bio, Inc.
United States · 1 relevant product
Atlas Link, Inc.
United States · 2 relevant products
Jei Daniel Biotech Corp.
Taiwan · 2 relevant products
Hangzhou Genesis Biodetection & Biocontrol Co., Ltd.
China · 3 relevant products
Bio-Novum Sp.z o.o.
Poland · 1 relevant product
59 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 111 closest product alternatives
Reagena Oy · Finland
A rapid diagnostic test intended for use as an aid in the diagnosis of Tick-borne encephalitis. The test helps identify infections transmitted by tick vectors.
Reagena Oy · Finland
Rapid diagnostic test for Tick-borne encephalitis virus detection, intended as an aid for diagnosis of TBE infection.
Citest Diagnostics Inc. · Canada
A rapid diagnostic test for the detection of Toxoplasma gondii IgG and IgM antibodies in serum or plasma samples.
Citest Diagnostics Inc. · Canada
A rapid diagnostic test for the detection of Toxoplasma gondii IgG and IgM antibodies in whole blood, serum, or plasma samples.
Hangzhou Frenovo Biotech Co., Ltd · China
Immunoglobulin-based rapid test for Toxoplasma gondii infection. Assists in diagnosis of toxoplasmosis in immunocompromised patients.
VEDALAB SAS · France
Immunochromatographic rapid test for qualitative detection of IgG antibodies to Toxoplasma gondii in whole blood, plasma, or serum samples. Enables quick serological assessment for toxoplasmosis diagnosis in clinical settings.
Prometheus Bio Inc. · China
Rapid immunoassay for detecting toxoplasma-specific IgG and IgM antibodies in serum. Used for serological diagnosis of toxoplasmosis in pregnant women and immunocompromised patients.
Reagena Oy · Finland
Rapid test system for detection of Tick-Borne Encephalitis antibodies. Part of the ReaScan rapid test portfolio for vector-borne disease diagnostics.
Access Bio, Inc. · United States
RAPID POC TEST is a point-of-care diagnostic kit for rapid detection of infectious diseases, including COVID-19, with FDA Emergency Use Authorization. The test delivers serology and molecular results within 10 minutes to 83 minutes, enabling quick identification of current infection and past exposure. Designed for clinical settings and emergency response distribution across healthcare facilities and screening programs.
Atlas Link, Inc. · United States
Lateral-flow immunoassay for qualitative detection of IgG antibodies to Toxoplasma. Component of congenital infection screening protocols.
Jei Daniel Biotech Corp. · Taiwan
Rapid point-of-care immunoglobulin G (IgG) test for serological detection of Echinococcosis infection. Enables quick identification of echinococcal antibodies in patient serum or plasma samples for clinical diagnosis and epidemiological screening in endemic regions.
Hangzhou Genesis Biodetection & Biocontrol Co., Ltd. · China
A rapid test for the detection of tuberculosis MPT64 antigen. Provides quick identification of Mycobacterium tuberculosis in clinical and laboratory environments.
99 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products